Mortalidad por infarto del miocardio en Chile: Trombolíticos o angioplastía

During recent decades, acute myocardial infarction short-term mortality has decreased to one digit levels, in the United States. Data from Chilean registries give figures around 11% for patients receiving thrombolysis, and 5 to 6 % for patients treated with angioplasty. The decrease in mortality in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Florenzano U,Fernando
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2011
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011001100001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872011001100001
record_format dspace
spelling oai:scielo:S0034-988720110011000012012-02-08Mortalidad por infarto del miocardio en Chile: Trombolíticos o angioplastíaFlorenzano U,Fernando Mortality Myocardial infarction Myocardial reperfusion Thrombolytic therapy During recent decades, acute myocardial infarction short-term mortality has decreased to one digit levels, in the United States. Data from Chilean registries give figures around 11% for patients receiving thrombolysis, and 5 to 6 % for patients treated with angioplasty. The decrease in mortality in Chile is related to the implementation of the AUGE program at a national level, initiative than gives patients the opportunity to receive at least thrombolytic therapy as well as a standardized and rapid diagnosis and treatment for this condition. There is a lack of Outcome Research studies in Chile, that would guide public health decisions such as the use of fibrin-specific agents for early presentation and high risk cases, and a rational system providing better access to primary angioplasty.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.139 n.11 20112011-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011001100001es10.4067/S0034-98872011001100001
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Mortality
Myocardial infarction
Myocardial reperfusion
Thrombolytic therapy
spellingShingle Mortality
Myocardial infarction
Myocardial reperfusion
Thrombolytic therapy
Florenzano U,Fernando
Mortalidad por infarto del miocardio en Chile: Trombolíticos o angioplastía
description During recent decades, acute myocardial infarction short-term mortality has decreased to one digit levels, in the United States. Data from Chilean registries give figures around 11% for patients receiving thrombolysis, and 5 to 6 % for patients treated with angioplasty. The decrease in mortality in Chile is related to the implementation of the AUGE program at a national level, initiative than gives patients the opportunity to receive at least thrombolytic therapy as well as a standardized and rapid diagnosis and treatment for this condition. There is a lack of Outcome Research studies in Chile, that would guide public health decisions such as the use of fibrin-specific agents for early presentation and high risk cases, and a rational system providing better access to primary angioplasty.
author Florenzano U,Fernando
author_facet Florenzano U,Fernando
author_sort Florenzano U,Fernando
title Mortalidad por infarto del miocardio en Chile: Trombolíticos o angioplastía
title_short Mortalidad por infarto del miocardio en Chile: Trombolíticos o angioplastía
title_full Mortalidad por infarto del miocardio en Chile: Trombolíticos o angioplastía
title_fullStr Mortalidad por infarto del miocardio en Chile: Trombolíticos o angioplastía
title_full_unstemmed Mortalidad por infarto del miocardio en Chile: Trombolíticos o angioplastía
title_sort mortalidad por infarto del miocardio en chile: trombolíticos o angioplastía
publisher Sociedad Médica de Santiago
publishDate 2011
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011001100001
work_keys_str_mv AT florenzanoufernando mortalidadporinfartodelmiocardioenchiletromboliticosoangioplastia
_version_ 1718436595573456896